ecancermedicalscience

Review

Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer

18 Sep 2017
Deep Pokharel, Ariane Roseblade, Vici Oenarto, Jamie F Lu, Mary Bebawy

Chemotherapy is an essential part of anticancer treatment. However, the overexpression of P-glycoprotein (P-gp) and the subsequent emergence of multidrug resistance (MDR) hampers successful treatment clinically. P-gp is a multidrug efflux transporter that functions to protect cells from xenobiotics by exporting them out from the plasma membrane to the extracellular space. P-gp inhibitors have been developed in an attempt to overcome P-gp-mediated MDR; however, lack of specificity and dose limiting toxicity have limited their effectiveness clinically. Recent studies report on accessory proteins that either directly or indirectly regulate P-gp expression and function and which are necessary for the establishment of the functional phenotype in cancer cells. This review discusses the role of these proteins, some of which have been recently proposed to comprise an interactive complex, and discusses their contribution towards MDR. We also discuss the role of other pathways and proteins in regulating P-gp expression in cells. The potential for these proteins as novel therapeutic targets provides new opportunities to circumvent MDR clinically.

Related Articles

Josepmilly del Valle Peña Colmenares, Carmen Cristina García, Yazmin José Velásquez Velásquez, Leider Arelis Campos Pino, Álvaro Gómez Rodríguez, Wladimir José Villegas Rodríguez, David José González Vargas, Douglas José Angulo Herrera
Josepmilly del Valle Peña Colmenares, Yazmin José Velásquez Velásquez, Wladimir José Villegas Rodríguez, Leider Arelis Campos Pino, Álvaro Gómez Rodríguez, Douglas José Angulo Herrera
João Henrique Fonseca do Nascimento, Cleonice Nascimento da Silva, André Gusmão-Cunha, Marinho Marques Silva Neto, André Bouzas de Andrade
Uchenna Simon Ezenkwa, Gabriel Olabiyi Ogun, Mbwas Isaac Mashor, Olufemi John Ogunbiyi